IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

Hack, SP; Verret, W; Mulla, S; Liu, B; Wang, YL; Macarulla, T; Ren, ZG; El-Khoueiry, AB; Zhu, AX

Hack, SP (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021; 13 ():

Abstract

Background: Biliary tract cancers (BTCs) are heterogenous, highly aggressive tumors that harbor a dismal prognosis for which more effective treatments......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索